Name: Global Ophthalmic Drug Delivery Device Market Research Report 2026-2035
Brand: Extent Research
Price: 3500 USD
Availability: InStock
Rating: 4.6 (186 reviews)

Global Ophthalmic Drug Delivery Device Market

Market Size in USD Billion

CAGR : 17.60%

USD 1.14

2025

USD 4.17

2033

Forecast Period	2025 - 2033
Market Size (Base Year)	USD 1.14 Billion
Market Size (Forecast)	USD 4.17 Billion
CAGR	17.60%
Major Market Players	Data provided in full report

The global Ophthalmic Drug Delivery Device Market focuses on encompassing major statistical evidence for the Ophthalmic Drug Delivery Device industry as it offers our readers a value addition on guiding them in encountering the obstacles surrounding the market. A comprehensive addition of several factors such as global distribution, manufacturers, market size, and market factors that affect the global contributions are reported in the study. The competitive landscape of the market study includes a wider analysis on the regions including North America, Europe, Asia Pacific, Latin America, Middle East & Africa, which are expected to capture the essence of the market in its widest category. In addition, the Ophthalmic Drug Delivery Device market study also covers several factors such as market status, key market trends, a growth forecast and growth opportunities. The study encompasses a variety of analytical resources such as SWOT analysis and Porters Five Forces analysis coupled with a primary and secondary research methodologies. It covers all the bases surrounding the Ophthalmic Drug Delivery Device industry as it explores the competitive nature of the market complete with a regional analysis.

Data provided by Extent Research. Source: https://www.extentresearch.com/ophthalmic-drug-delivery-device-market

In addition, the Ophthalmic Drug Delivery Device study also shifts its attention with an in-depth competitive landscape, defined growth opportunities, market share coupled with product type and applications, key companies responsible for production and utilized strategies are also marked. Some of the key players operating in the global Ophthalmic Drug Delivery Device market include Aero Pump GmbH, AptarGroup, Bausch Health, Becton Dickinson & Company, EyePoint Pharmaceuticals, Inc., Gaplast GmbH, Gerresheimer, Nemera, Nipro Corporation, Ocular Therapeutix, Owen Mumford, Silgan Holdings Inc., Terumo Corporation, West Pharmaceutical Services, Inc., Kedalion Therapeutics, Re-Vana Therapeutics, Mati Therapeutics, Inc.,, Biocorp Production, Ocumedic, Inc., . The list covers significant players that govern the industry based on overall system production capabilities, environmental contributions, appropriate channels, and territorial nearness through a system of primary and secondary research methodologies further followed by an in-house analytical model. Furthermore, we analyze the challenges faced by the Ophthalmic Drug Delivery Device market in terms of global and regional basis. The study also encompasses a number of opportunity and emerging trends which are considered by considering their impact on the global scale in acquiring a majority of the market share.

Segmentation of the Global Ophthalmic Drug Delivery Device Market:

By Product type

Pre-Filled Syringes, Multidose Eyedroppers, Squeeze Dispenser, Mist Sprayers, Add-On Devices, Contact Lenses, Others,

by Application

Hospitals, Clinics, Homecare, Others,

Report Scope and Market Segmentation

ATTRIBUTES	Global Ophthalmic Drug Delivery Device Market KEY MARKET INSIGHTS
Segments Covered	By Product Type: All Products Type Includes By Application: All Application Type Includes By End User: All End User Type Includes By Distribution Channel: All Distribution Channel Includes
Countries Covered	North America U.S., Canada, Mexico Europe Germany, United Kingdom, France, Italy, Spain, Nordic Countries, Benelux Union, Rest of Europe Asia-Pacific China, India, Japan, New Zealand, South Korea, Australia, Southeast Asia, Rest of Asia Pacific Latin America Brazil, Argentina, Rest of Latin America Middle East & Africa Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa
Key Market Players	Leading Tier 1 Corporations Prominent Regional Manufacturers Emerging Market Disruptors Technology Integrators & Suppliers *Complete vendor layout of 15+ major players provided in the final report.
Market Opportunities	Market Size and Growth: Quantifying the total addressable market (TAM) and projected growth rates to assess financial viability. Customer Segmentation: Identifying target audience behaviors, pain points, and specific unfulfilled demands. Competitive Landscape: Analyzing existing competitors' strengths, weaknesses, and market share to pinpoint gaps and opportunities. Industry Trends: Mapping technological, regulatory, and economic shifts that create favorable conditions for market entry. Risk Assessment: Evaluating barriers to entry and operational challenges alongside strategic roadmaps for mitigation.
Value Added Data Infosets	In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by our expert team also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.

Meet the Team

Julie

Author

Julie Jayne is a distinguished multidisciplinary strategist and the Head of Research at Extent Research, where she leverages over a decade of comprehensive experience in the global market intelligence industry. Backed by a robust academic foundation that includes a B.Sc. and an MBA, she perfectly...

Priya M

Reviewed By

With over 14 years of dedicated professional expertise in business-to-business (B2B) intelligence, Priya M stands as a distinguished leader in corporate strategy, revenue growth, and advanced data analysis. Her dynamic career is defined by a relentless focus on mitigating business risks and empowering corporate executives...

Learn more about Priya M

BASIC ATTRIBUTES \| KEY MARKET INSIGHTS
Report Title	Global Ophthalmic Drug Delivery Device Market
Base Year	2025
Forecast Period	2025 - 2033
Market Size (Base)	USD 1.14 Billion
Projected Size	USD 4.17 Billion
CAGR	17.60%

                            1 Ophthalmic Drug Delivery Device Market Overview
    1.1 Product Overview and Scope of Ophthalmic Drug Delivery Device
    1.2 Ophthalmic Drug Delivery Device Segment by Type
        1.2.1 Global Ophthalmic Drug Delivery Device Sales Growth Rate Comparison by Type (2022-2035)
        1.2.2 Pre-Filled Syringes
        1.2.3 Multidose Eyedroppers
        1.2.4 Squeeze Dispenser
        1.2.5 Mist Sprayers
        1.2.6 Add-On Devices
        1.2.7 Contact Lenses
        1.2.8 Others
    1.3 Ophthalmic Drug Delivery Device Segment by Application
        1.3.1 Global Ophthalmic Drug Delivery Device Sales Comparison by Application: (2022-2035)
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Homecare
        1.3.5 Others
    1.4 Global Ophthalmic Drug Delivery Device Market Size Estimates and Forecasts
        1.4.1 Global Ophthalmic Drug Delivery Device Revenue 2017-2035
        1.4.2 Global Ophthalmic Drug Delivery Device Sales 2017-2035
        1.4.3 Ophthalmic Drug Delivery Device Market Size by Region: 2017 Versus 2021 Versus 2035
2 Ophthalmic Drug Delivery Device Market Competition by Manufacturers
    2.1 Global Ophthalmic Drug Delivery Device Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Ophthalmic Drug Delivery Device Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Ophthalmic Drug Delivery Device Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Ophthalmic Drug Delivery Device Manufacturing Sites, Area Served, Product Type
    2.5 Ophthalmic Drug Delivery Device Market Competitive Situation and Trends
        2.5.1 Ophthalmic Drug Delivery Device Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Ophthalmic Drug Delivery Device Players Market Share by Revenue
        2.5.3 Global Ophthalmic Drug Delivery Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Ophthalmic Drug Delivery Device Retrospective Market Scenario by Region
    3.1 Global Ophthalmic Drug Delivery Device Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Ophthalmic Drug Delivery Device Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Ophthalmic Drug Delivery Device Market Facts & Figures by Country
        3.3.1 North America Ophthalmic Drug Delivery Device Sales by Country
        3.3.2 North America Ophthalmic Drug Delivery Device Revenue by Country
        3.3.3 United States
        3.3.4 Canada
    3.4 Europe Ophthalmic Drug Delivery Device Market Facts & Figures by Country
        3.4.1 Europe Ophthalmic Drug Delivery Device Sales by Country
        3.4.2 Europe Ophthalmic Drug Delivery Device Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Ophthalmic Drug Delivery Device Market Facts & Figures by Region
        3.5.1 Asia Pacific Ophthalmic Drug Delivery Device Sales by Region
        3.5.2 Asia Pacific Ophthalmic Drug Delivery Device Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 China Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
    3.6 Latin America Ophthalmic Drug Delivery Device Market Facts & Figures by Country
        3.6.1 Latin America Ophthalmic Drug Delivery Device Sales by Country
        3.6.2 Latin America Ophthalmic Drug Delivery Device Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
        3.6.6 Colombia
    3.7 Middle East and Africa Ophthalmic Drug Delivery Device Market Facts & Figures by Country
        3.7.1 Middle East and Africa Ophthalmic Drug Delivery Device Sales by Country
        3.7.2 Middle East and Africa Ophthalmic Drug Delivery Device Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Ophthalmic Drug Delivery Device Historic Market Analysis by Type
    4.1 Global Ophthalmic Drug Delivery Device Sales Market Share by Type (2017-2022)
    4.2 Global Ophthalmic Drug Delivery Device Revenue Market Share by Type (2017-2022)
    4.3 Global Ophthalmic Drug Delivery Device Price by Type (2017-2022)
5 Global Ophthalmic Drug Delivery Device Historic Market Analysis by Application
    5.1 Global Ophthalmic Drug Delivery Device Sales Market Share by Application (2017-2022)
    5.2 Global Ophthalmic Drug Delivery Device Revenue Market Share by Application (2017-2022)
    5.3 Global Ophthalmic Drug Delivery Device Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Aero Pump GmbH
        6.1.1 Aero Pump GmbH Corporation Information
        6.1.2 Aero Pump GmbH Description and Business Overview
        6.1.3 Aero Pump GmbH Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Aero Pump GmbH Ophthalmic Drug Delivery Device Product Portfolio
        6.1.5 Aero Pump GmbH Recent Developments/Updates
    6.2 AptarGroup
        6.2.1 AptarGroup Corporation Information
        6.2.2 AptarGroup Description and Business Overview
        6.2.3 AptarGroup Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 AptarGroup Ophthalmic Drug Delivery Device Product Portfolio
        6.2.5 AptarGroup Recent Developments/Updates
    6.3 Bausch Health
        6.3.1 Bausch Health Corporation Information
        6.3.2 Bausch Health Description and Business Overview
        6.3.3 Bausch Health Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Bausch Health Ophthalmic Drug Delivery Device Product Portfolio
        6.3.5 Bausch Health Recent Developments/Updates
    6.4 Becton Dickinson & Company
        6.4.1 Becton Dickinson & Company Corporation Information
        6.4.2 Becton Dickinson & Company Description and Business Overview
        6.4.3 Becton Dickinson & Company Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Becton Dickinson & Company Ophthalmic Drug Delivery Device Product Portfolio
        6.4.5 Becton Dickinson & Company Recent Developments/Updates
    6.5 EyePoint Pharmaceuticals, Inc.
        6.5.1 EyePoint Pharmaceuticals, Inc. Corporation Information
        6.5.2 EyePoint Pharmaceuticals, Inc. Description and Business Overview
        6.5.3 EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery Device Product Portfolio
        6.5.5 EyePoint Pharmaceuticals, Inc. Recent Developments/Updates
    6.6 Gaplast GmbH
        6.6.1 Gaplast GmbH Corporation Information
        6.6.2 Gaplast GmbH Description and Business Overview
        6.6.3 Gaplast GmbH Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 Gaplast GmbH Ophthalmic Drug Delivery Device Product Portfolio
        6.6.5 Gaplast GmbH Recent Developments/Updates
    6.7 Gerresheimer
        6.6.1 Gerresheimer Corporation Information
        6.6.2 Gerresheimer Description and Business Overview
        6.6.3 Gerresheimer Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Gerresheimer Ophthalmic Drug Delivery Device Product Portfolio
        6.7.5 Gerresheimer Recent Developments/Updates
    6.8 Nemera
        6.8.1 Nemera Corporation Information
        6.8.2 Nemera Description and Business Overview
        6.8.3 Nemera Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 Nemera Ophthalmic Drug Delivery Device Product Portfolio
        6.8.5 Nemera Recent Developments/Updates
    6.9 Nipro Corporation
        6.9.1 Nipro Corporation Corporation Information
        6.9.2 Nipro Corporation Description and Business Overview
        6.9.3 Nipro Corporation Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 Nipro Corporation Ophthalmic Drug Delivery Device Product Portfolio
        6.9.5 Nipro Corporation Recent Developments/Updates
    6.10 Ocular Therapeutix
        6.10.1 Ocular Therapeutix Corporation Information
        6.10.2 Ocular Therapeutix Description and Business Overview
        6.10.3 Ocular Therapeutix Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
        6.10.4 Ocular Therapeutix Ophthalmic Drug Delivery Device Product Portfolio
        6.10.5 Ocular Therapeutix Recent Developments/Updates
    6.11 Owen Mumford
        6.11.1 Owen Mumford Corporation Information
        6.11.2 Owen Mumford Ophthalmic Drug Delivery Device Description and Business Overview
        6.11.3 Owen Mumford Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
        6.11.4 Owen Mumford Ophthalmic Drug Delivery Device Product Portfolio
        6.11.5 Owen Mumford Recent Developments/Updates
    6.12 Silgan Holdings Inc.
        6.12.1 Silgan Holdings Inc. Corporation Information
        6.12.2 Silgan Holdings Inc. Ophthalmic Drug Delivery Device Description and Business Overview
        6.12.3 Silgan Holdings Inc. Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
        6.12.4 Silgan Holdings Inc. Ophthalmic Drug Delivery Device Product Portfolio
        6.12.5 Silgan Holdings Inc. Recent Developments/Updates
    6.13 Terumo Corporation
        6.13.1 Terumo Corporation Corporation Information
        6.13.2 Terumo Corporation Ophthalmic Drug Delivery Device Description and Business Overview
        6.13.3 Terumo Corporation Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
        6.13.4 Terumo Corporation Ophthalmic Drug Delivery Device Product Portfolio
        6.13.5 Terumo Corporation Recent Developments/Updates
    6.14 West Pharmaceutical Services, Inc.
        6.14.1 West Pharmaceutical Services, Inc. Corporation Information
        6.14.2 West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery Device Description and Business Overview
        6.14.3 West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
        6.14.4 West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery Device Product Portfolio
        6.14.5 West Pharmaceutical Services, Inc. Recent Developments/Updates
    6.15 Kedalion Therapeutics
        6.15.1 Kedalion Therapeutics Corporation Information
        6.15.2 Kedalion Therapeutics Ophthalmic Drug Delivery Device Description and Business Overview
        6.15.3 Kedalion Therapeutics Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
        6.15.4 Kedalion Therapeutics Ophthalmic Drug Delivery Device Product Portfolio
        6.15.5 Kedalion Therapeutics Recent Developments/Updates
    6.16 Re-Vana Therapeutics
        6.16.1 Re-Vana Therapeutics Corporation Information
        6.16.2 Re-Vana Therapeutics Ophthalmic Drug Delivery Device Description and Business Overview
        6.16.3 Re-Vana Therapeutics Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
        6.16.4 Re-Vana Therapeutics Ophthalmic Drug Delivery Device Product Portfolio
        6.16.5 Re-Vana Therapeutics Recent Developments/Updates
    6.17 Mati Therapeutics, Inc.,
        6.17.1 Mati Therapeutics, Inc., Corporation Information
        6.17.2 Mati Therapeutics, Inc., Ophthalmic Drug Delivery Device Description and Business Overview
        6.17.3 Mati Therapeutics, Inc., Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
        6.17.4 Mati Therapeutics, Inc., Ophthalmic Drug Delivery Device Product Portfolio
        6.17.5 Mati Therapeutics, Inc., Recent Developments/Updates
    6.18 Biocorp Production
        6.18.1 Biocorp Production Corporation Information
        6.18.2 Biocorp Production Ophthalmic Drug Delivery Device Description and Business Overview
        6.18.3 Biocorp Production Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
        6.18.4 Biocorp Production Ophthalmic Drug Delivery Device Product Portfolio
        6.18.5 Biocorp Production Recent Developments/Updates
    6.19 Ocumedic, Inc.
        6.19.1 Ocumedic, Inc. Corporation Information
        6.19.2 Ocumedic, Inc. Ophthalmic Drug Delivery Device Description and Business Overview
        6.19.3 Ocumedic, Inc. Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
        6.19.4 Ocumedic, Inc. Ophthalmic Drug Delivery Device Product Portfolio
        6.19.5 Ocumedic, Inc. Recent Developments/Updates
7 Ophthalmic Drug Delivery Device Manufacturing Cost Analysis
    7.1 Ophthalmic Drug Delivery Device Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Ophthalmic Drug Delivery Device
    7.4 Ophthalmic Drug Delivery Device Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Ophthalmic Drug Delivery Device Distributors List
    8.3 Ophthalmic Drug Delivery Device Customers
9 Ophthalmic Drug Delivery Device Market Dynamics
    9.1 Ophthalmic Drug Delivery Device Industry Trends
    9.2 Ophthalmic Drug Delivery Device Market Drivers
    9.3 Ophthalmic Drug Delivery Device Market Challenges
    9.4 Ophthalmic Drug Delivery Device Market Restraints
10 Global Market Forecast
    10.1 Ophthalmic Drug Delivery Device Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Ophthalmic Drug Delivery Device by Type (2023-2035)
        10.1.2 Global Forecasted Revenue of Ophthalmic Drug Delivery Device by Type (2023-2035)
    10.2 Ophthalmic Drug Delivery Device Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Ophthalmic Drug Delivery Device by Application (2023-2035)
        10.2.2 Global Forecasted Revenue of Ophthalmic Drug Delivery Device by Application (2023-2035)
    10.3 Ophthalmic Drug Delivery Device Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Ophthalmic Drug Delivery Device by Region (2023-2035)
        10.3.2 Global Forecasted Revenue of Ophthalmic Drug Delivery Device by Region (2023-2035)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer                        

Research Methodology

Data collection and base year analysis are done using proprietary data collection modules with large sample sizes. The process includes obtaining market information through extensive secondary sources, paid databases, and verifying data via primary (industry expert) validation.

Our market models include Vendor Positioning Grids, Market Timeline Analysis, Company Market Share Analysis, and Top-Down/Bottom-Up forecasting models. To know more about the research methodology, drop an inquiry to speak to our industry experts.

Speak to Analyst

Global Ophthalmic Drug Delivery Device Market